Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
J Proteomics ; 272: 104776, 2023 02 10.
Artículo en Inglés | MEDLINE | ID: mdl-36423857

RESUMEN

Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron degenerative disease, and the pathogenic mechanism that underlies ALS is still unclear. We analyzed the differentially expressed proteins (DEPs) in the spinal cord between SOD1-G93A transgenic mice at the onset stage and non-transgenic (NTG) littermates based on 4D label-free quantitative proteomics (4D-LFQ) with liquid chromatography-tandem mass spectrometry (LC-MS/MS). In our study, 189 DEPs were screened, of which 166 were up-regulated and 23 down-regulated. Clusters of Orthologous Groups (COG)/ EuKaryotic Orthologous Groups (KOG) classification, subcellular localization annotation, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment, clustering analysis and protein-protein interaction (PPI) network analyses were performed. Parallel reaction monitoring (PRM) analysis validated 48 proteins from immunity and inflammation-related pathways of KEGG. We described the function and distribution of DEPs, most of which were involved in the following pathways: complement and coagulation cascades, antigen processing and presentation, NF-kappa B signaling pathway, Retinoic acid-inducible gene I (RIG) -I-like receptor signaling pathway, the extracellular matrix-receptor (ECM-receptor) interaction, focal adhesion, phagosome and lysosome. PPI network analysis identified Fn1, Fga, Serpina1e and Serpina3n as potential biomarkers. Our discoveries broaden the view and expand our understanding of immunity and inflammation in ALS. SIGNIFICANCE: This study gives a comprehensive description of DEPs in the spinal cord proteomics of SOD1-G93A mice at the onset period. Compared with a previous study focusing on progressive stage, we showed that immunity and inflammation play an important role at the onset stage of ALS. Several pathways validated by PRM bring new insight to the pathological mechanisms of ALS. The participation of RIG-I-like signaling pathway in ALS and potential biomarkers Fga, Fn1, Serpina1e and Serpina3n are supplements to existing knowledge.


Asunto(s)
Esclerosis Amiotrófica Lateral , Ratones , Animales , Esclerosis Amiotrófica Lateral/genética , Esclerosis Amiotrófica Lateral/metabolismo , Esclerosis Amiotrófica Lateral/patología , Superóxido Dismutasa-1/genética , Superóxido Dismutasa-1/metabolismo , Proteómica , Cromatografía Liquida , Espectrometría de Masas en Tándem , Ratones Transgénicos , Médula Espinal/metabolismo , Médula Espinal/patología , Inflamación/metabolismo , Modelos Animales de Enfermedad , Superóxido Dismutasa/genética , Superóxido Dismutasa/metabolismo
2.
Int J Mol Sci ; 17(11)2016 Nov 22.
Artículo en Inglés | MEDLINE | ID: mdl-27879679

RESUMEN

Tumor necrosis factor (TNF)-α is a pleiotropic cytokine with intense pro-inflammatory and immunomodulatory properties, and anti-TNF-α biologics are effective therapies for various inflammatory diseases such as inflammatory bowel disease (IBD) and sepsis. Snake venom, as a traditional Chinese medicine, has been used in the treatment of inflammatory diseases in China for centuries. In this research, we constructed a venom gland T7 phage display library of the sea snake Hydrophis cyanocinctus to screen bioactive compounds that antagonize TNF-α and identified a novel nine-amino-acid peptide, termed hydrostatin-TL1 (H-TL1). In enzyme-linked immunosorbent assay (ELISA) and surface plasmon resonance (SPR) analyses, H-TL1 inhibited the interaction between TNF-α and TNF receptor 1 (TNFR1). Further, H-TL1 attenuated the cytotoxicity of TNF-α in L929 cells as determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. H-TL1 also decreased the mRNA expression of TNF-α/TNFR1 downstream targets and suppressed the phosphorylation of well-characterized proteins of downstream signal transduction pathways in HEK-293 cells. In vivo data demonstrated that H-TL1 protects animals against dextran sodium sulfate (DSS)-induced acute colitis and lipopolysaccharide (LPS)-induced acute shock. Given its significant anti-inflammatory activity in vitro and in vivo, H-TL1 is a potential peptide for the development of new agents to treat TNF-α-associated inflammatory diseases.


Asunto(s)
Antiinflamatorios/farmacología , Colitis/tratamiento farmacológico , Venenos Elapídicos/farmacología , Oligopéptidos/farmacología , Receptores Tipo I de Factores de Necrosis Tumoral/antagonistas & inhibidores , Proteínas de Reptiles/farmacología , Choque Séptico/tratamiento farmacológico , Venenos de Serpiente/química , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Enfermedad Aguda , Animales , Antiinflamatorios/síntesis química , Antiinflamatorios/aislamiento & purificación , Línea Celular , Supervivencia Celular/efectos de los fármacos , Colitis/inducido químicamente , Colitis/genética , Colitis/patología , Colubridae/metabolismo , Sulfato de Dextran , Venenos Elapídicos/síntesis química , Venenos Elapídicos/aislamiento & purificación , Quinasas MAP Reguladas por Señal Extracelular/química , Quinasas MAP Reguladas por Señal Extracelular/genética , Fibroblastos/citología , Fibroblastos/efectos de los fármacos , Fibroblastos/metabolismo , Regulación de la Expresión Génica , Células HEK293 , Humanos , Lipopolisacáridos , Ratones , Oligopéptidos/síntesis química , Oligopéptidos/aislamiento & purificación , Biblioteca de Péptidos , Fosforilación , Receptores Tipo I de Factores de Necrosis Tumoral/química , Receptores Tipo I de Factores de Necrosis Tumoral/genética , Proteínas de Reptiles/síntesis química , Proteínas de Reptiles/aislamiento & purificación , Choque Séptico/inducido químicamente , Choque Séptico/genética , Choque Séptico/patología , Transducción de Señal , Venenos de Serpiente/aislamiento & purificación , Transcripción Genética , Factor de Necrosis Tumoral alfa/química , Factor de Necrosis Tumoral alfa/genética , Proteínas Quinasas p38 Activadas por Mitógenos/química , Proteínas Quinasas p38 Activadas por Mitógenos/genética
3.
Hear Res ; 333: 150-156, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-26805025

RESUMEN

Auditory enhancement refers to the observation that the salience of one spectral region (the "signal") of a broadband sound can be enhanced and can "pop out" from the remainder of the sound (the "masker") if it is preceded by the broadband sound without the signal. The present study investigated auditory enhancement as an effective change in loudness, to determine whether it reflects a change in the loudness of the signal, the masker, or both. In the first experiment, the 500-ms precursor, an inharmonic complex with logarithmically spaced components, was followed after a 50-ms gap by the 100-ms signal or masker alone, the loudness of which was compared with that of the same signal or masker presented 2 s later. In the second experiment, the loudness of the signal embedded in the masker was assessed with and without a precursor using the same method, as was the loudness of the entire signal-plus-masker complex. The results suggest that the precursor does not affect the loudness of the signal or the masker alone, but enhances the loudness of the signal in the presence of the masker, while leaving the loudness of the surrounding masker unaffected. The results are consistent with an explanation based on "adaptation of inhibition" [Viemeister and Bacon (1982). J. Acoust. Soc. Am. 71, 1502-1507].


Asunto(s)
Corteza Auditiva/fisiología , Señales (Psicología) , Percepción Sonora , Ruido/efectos adversos , Enmascaramiento Perceptual , Estimulación Acústica/métodos , Acústica , Adaptación Fisiológica , Adolescente , Adulto , Anciano , Audiometría , Vías Auditivas/fisiología , Umbral Auditivo , Femenino , Humanos , Masculino , Persona de Mediana Edad , Inhibición Neural , Psicoacústica , Espectrografía del Sonido , Factores de Tiempo , Adulto Joven
4.
J Acoust Soc Am ; 136(3): 1237, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-25190397

RESUMEN

Spectral contrast effects may help "normalize" the incoming sound and produce perceptual constancy in the face of the variable acoustics produced by different rooms, talkers, and backgrounds. Recent studies have concentrated on the after-effects produced by the long-term average power spectrum. The present study examined contrast effects based on spectral motion, analogous to visual-motion after-effects. In experiment 1, the existence of spectral-motion after-effects with word-length inducers was established by demonstrating that the identification of the direction of a target spectral glide was influenced by the spectral motion of a preceding inducer glide. In experiment 2, the target glide was replaced with a synthetic sine-wave speech sound, including a formant transition. The speech category boundary was shifted by the presence and direction of the inducer glide. Finally, in experiment 3, stimuli based on synthetic sine-wave speech sounds were used as both context and target stimuli to show that the spectral-motion after-effects could occur even with inducers with relatively short speech-like durations and small frequency excursions. The results suggest that spectral motion may play a complementary role to the long-term average power spectrum in inducing speech context effects.


Asunto(s)
Percepción del Habla , Estimulación Acústica , Adolescente , Adulto , Audiometría , Umbral Auditivo , Femenino , Humanos , Masculino , Ruido/efectos adversos , Enmascaramiento Perceptual , Factores de Tiempo , Calidad de la Voz , Adulto Joven
5.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 25(10): 916-9, 2005 Oct.
Artículo en Chino | MEDLINE | ID: mdl-16313117

RESUMEN

OBJECTIVE: To observe whether ginsenoside Rg1 could reduce the infarcted area and improve the heart function by path of promoting bone marrow stem cells differentiated to vascular endothelial cells (VECs). METHODS: Bone marrow was drawn from rabbit's ilium and labelled with red fluorochrome DiI, then it was transferred again into the rabbit's body. The rabbits was then made into myocardiac infarction model. The model rabbits were divided into the control group and the ginsenoside Rgl treated group (treated group). The infracted area at two weeks, and the left ventricular function at one and two weeks after infarction were determined respectively. The DiI positive cell rate of myelogenetic cells in ischmia area and CD31 positive cell rate of VECs were determined by confocal microscopy. Myocardial interstitial granulocyte colony-stimulating factor(GCSF) levels during ischemia and reperfusion period were determined also. RESULTS: DiI positive rate of CD31 staining positive cells in the treated group was obviously increased, and the concentration of G-CSF in myocardium interstitial obviously increased, accompanied with obviously improving of heart function and obviously reducing of infarcted area. CONCLUSION: Ginsenoside Rgl could stimulate the G-CSF secretion in local myocardiac tissues, thus to induce bone marrow mononuclear cells migrate to myocadial tissue and further differentiate to VECs. The regeneration of endothelium cells show certain direct action in promoting capillary regeneration of infarcted myocardium tissue and maintaining the blood supply.


Asunto(s)
Diferenciación Celular/efectos de los fármacos , Células Endoteliales/citología , Ginsenósidos/farmacología , Células Madre Multipotentes/citología , Infarto del Miocardio/patología , Animales , Células de la Médula Ósea/citología , Movimiento Celular/efectos de los fármacos , Circulación Coronaria/efectos de los fármacos , Factor Estimulante de Colonias de Granulocitos/biosíntesis , Masculino , Infarto del Miocardio/metabolismo , Conejos
6.
Am J Chin Med ; 32(4): 587-98, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15481648

RESUMEN

Lindera strychnifolia (tendai-uyaku), a medicinal plant, has long been used for the treatment of cardiac, renal and rheumatic diseases in Japan. We aim to clarify (1) whether L. strychnifolia is protective against post-ischemic myocardial dysfunction, and (2) whether its effect is related to scavenging hydroxyl radicals and opening the mitochondrial KATP channels in isolated rat hearts. Male Sprague-Dawley rats were orally given 1 ml/day of L. strychnifolia, which was extracted from 0.75 and 1.5 g/kg of roots of L. strychnifolia for 4 days. The rat hearts were excised and perfused on a Langendorff apparatus with Krebs-Henseleit solution with a gas mixture of 95% O2 and 5% CO2. The hearts were paced at 320 beats/min except during ischemia. Left ventricular developed pressure (LVDP, mmHg), +/- dP/dt (mmHg/sec) and coronary flow (ml/min) were continuously monitored. All hearts were perfused for a total of 120 minutes consisting of a 30-minute pre-ischemic period followed by 30 minutes of global ischemia and 60 minutes of reperfusion with or without 5-HD, a mitochondrial KATP channel blocker. The levels of lactate, LDH and 2,5-DHBA, an indicator of hydroxyl radicals, in the perfusate during reperfusion period were also measured. Treatment with L. strychnifolia significantly improved LVDP and +/- dP/dt without altering coronary flow during reperfusion. The 100 microM of 5-HD in Krebs-Henseleit solution was perfused during the 10 minutes of pre-ischemic periods. Pretreatment with 5-HD abolished the improvement of LVDP and +/- dP/dt by L. strychnifolia. L. strychnifolia significantly attenuated the levels of lactate, LDH and 2,5-DHBA during reperfusion, and which were restored by pretreatment with 5-HD. In conclusion, L. strychnifolia is protective against post-ischemic left ventricular dysfunction through scavenging hydroxyl radicals and opening the KATP channels in the isolated rat heart.


Asunto(s)
Corazón/efectos de los fármacos , Radical Hidroxilo/metabolismo , Lindera , Proteínas de la Membrana/fisiología , Isquemia Miocárdica/prevención & control , Preparaciones de Plantas/farmacología , Animales , Cromatografía Líquida de Alta Presión/métodos , Gentisatos/metabolismo , Corazón/fisiopatología , Técnicas In Vitro , L-Lactato Deshidrogenasa/metabolismo , Masculino , Isquemia Miocárdica/metabolismo , Isquemia Miocárdica/fisiopatología , Preparaciones de Plantas/uso terapéutico , Canales de Potasio , Ratas , Ratas Sprague-Dawley , Función Ventricular Izquierda/efectos de los fármacos
7.
Circulation ; 109(21): 2572-80, 2004 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-15123535

RESUMEN

BACKGROUND: We investigated whether the improvement of cardiac function and remodeling after myocardial infarction (MI) by granulocyte colony-stimulating factor (G-CSF) relates to acceleration of the healing process, in addition to myocardial regeneration. METHODS AND RESULTS: In a 30-minute coronary occlusion and reperfusion rabbit model, saline (S) or 10 microg x kg(-1) x d(-1) of human recombinant G-CSF (G) was injected subcutaneously from 1 to 5 days after MI. Smaller left ventricular (LV) dimension, increased LV ejection fraction, and thicker infarct-LV wall were seen in G at 3 months after MI. At 2, 7, and 14 days and 3 months after MI, necrotic tissue areas were 14.2+/-1.5/13.4+/-1.1, 0.4+/-0.1/1.8+/-0.5*, 0/0, and 0/0 mm2 x slice(-1) x kg(-1), granulation areas 0/0, 4.0+/-0.7/8.5+/-1.0*, 3.9+/-0.8/5.7+/-0.7,* and 0/0 mm2 x slice(-1) x kg(-1), and scar areas 0/0, 0/0, 0/0, and 4.2+/-0.5/7.9+/-0.9* mm2 x slice(-1) x kg(-1) in G and S, respectively (*P<0.05, G versus S). Clear increases of macrophages and of matrix metalloproteinases (MMP) 1 and 9 were seen in G at 7 days after MI. This suggests that G accelerates absorption of necrotic tissues via increase of macrophages and reduces granulation and scar tissues via expression of MMPs. Meanwhile, surviving myocardial tissue areas within the risk areas were significantly increased in G despite there being no difference in LV weight, LV wall area, or cardiomyocyte size between G and S. Confocal microscopy revealed significant increases of cardiomyocytes with positive 3,3,3',3'-tetramethylindocarbocyanine perchlorate and positive troponin I in G, suggesting enhanced myocardial regeneration by G. CONCLUSIONS: The acceleration of the healing process and myocardial regeneration may play an important role for the beneficial effect of post-MI G-CSF treatment.


Asunto(s)
Factor Estimulante de Colonias de Granulocitos/uso terapéutico , Corazón/efectos de los fármacos , Infarto del Miocardio/tratamiento farmacológico , Miocardio/patología , Remodelación Ventricular/efectos de los fármacos , Animales , Tamaño de la Célula/efectos de los fármacos , Cicatriz/etiología , Cicatriz/patología , Cicatriz/prevención & control , Evaluación Preclínica de Medicamentos , Ecocardiografía , Tejido de Granulación/patología , Factor Estimulante de Colonias de Granulocitos/farmacología , Macrófagos/fisiología , Metaloproteinasa 1 de la Matriz/análisis , Metaloproteinasa 9 de la Matriz/análisis , Microscopía Confocal , Infarto del Miocardio/patología , Infarto del Miocardio/fisiopatología , Miocardio/enzimología , Miocitos Cardíacos/efectos de los fármacos , Conejos , Proteínas Recombinantes/farmacología , Proteínas Recombinantes/uso terapéutico , Regeneración/efectos de los fármacos
8.
J Am Coll Cardiol ; 40(7): 1347-55, 2002 Oct 02.
Artículo en Inglés | MEDLINE | ID: mdl-12383585

RESUMEN

OBJECTIVE: We aimed to clarify the relation between sarpogrelate (SG), a 5-hydroxytryptamine (5-HT)-2 receptor blocker, and myocardial interstitial serotonin or infarct size during ischemia and reperfusion. BACKGROUND: In cardiac tissues serotonin is rich in vascular platelets, mast cells, sympathetic nerve endings, and the receptors are present in platelets and cardiomyocytes. METHODS: The myocardial interstitial serotonin levels were measured using a microdialysis technique during 30-min ischemia with and without SG in in vivo as well as isolated rabbit hearts. Other rabbits underwent 30 min of ischemia and 48 h of reperfusion, and the effect of SG on the infarct size was investigated in the absence and presence of a selective protein kinase C (PKC) inhibitor, chelerythrine (5 mg/kg, intravenously), or a mitochondrial adenosine triphosphate sensitive potassium (KATP) channel blocker, 5-hydroxydecanoate (5-HD) (5 mg/kg, intravenously). In another series, the effect of SG on PKC isoforms in cytosol and membrane fraction was assessed after a 20-min global ischemia in isolated rabbit hearts. RESULTS: Interstitial serotonin levels were markedly increased during 30-min ischemia in in vivo and isolated hearts, and the increases were inhibited by SG in each. The infarct size was reduced by SG (27 +/- 2% vs. 40 +/- 3% of control). This effect was blocked by chelerythrine and 5-HD, respectively. Sarpogrelate further enhanced the ischemia-induced translocation of PKC-epsilon to the membrane fraction. CONCLUSIONS: Sarpogrelate reduces the myocardial infarct size by inhibiting the serotonin release followed by enhancement of PKC-epsilon translocation and opening of the mitochondrial KATP channel in ischemic myocytes.


Asunto(s)
Modelos Animales de Enfermedad , Infarto del Miocardio/tratamiento farmacológico , Infarto del Miocardio/etiología , Receptores de Serotonina/efectos de los fármacos , Antagonistas de la Serotonina/uso terapéutico , Serotonina/fisiología , Succinatos/uso terapéutico , Adenosina Trifosfato/fisiología , Alcaloides , Animales , Benzofenantridinas , Ácidos Decanoicos/farmacología , Evaluación Preclínica de Medicamentos , Hemodinámica/efectos de los fármacos , Hemodinámica/fisiología , Hidroxiácidos/farmacología , Técnicas In Vitro , Isoenzimas/análisis , Isoenzimas/efectos de los fármacos , Isoenzimas/fisiología , Infarto del Miocardio/patología , Infarto del Miocardio/fisiopatología , Fenantridinas/farmacología , Bloqueadores de los Canales de Potasio/farmacología , Proteína Quinasa C/análisis , Proteína Quinasa C/antagonistas & inhibidores , Proteína Quinasa C/efectos de los fármacos , Proteína Quinasa C/fisiología , Proteína Quinasa C-epsilon , Conejos , Serotonina/análisis , Antagonistas de la Serotonina/farmacología , Succinatos/farmacología
9.
Circ J ; 66(8): 763-8, 2002 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12197603

RESUMEN

The present study used isolated rat hearts to investigate whether (1) Sheng-Mei-San (SMS), a traditional Chinese formulation comprising Radix Ginseng, Radix Ophiopogonis and Fructus Schisandrae, is protective against post-ischemic myocardial dysfunction, and (2) whether the cardioprotective effect of SMS is related to scavenging of hydroxyl radicals and opening the mitochondrial KATP channels. The excised hearts of male Sprague-Dawley rats were perfused on a Langendorff apparatus with Krebs-Henseleit solution with a gas mixture of 95% O2 and 5% CO2. Left ventricular end-diastolic pressure (LVEDP, mmHg), left ventricular developed pressure (LVDP, mmHg), +/-dP/dt (mmHg/s) and coronary flow (ml/min) were continuously monitored. All hearts were perfused for a total of 120 min consisting of a 30-min pre-ischemic period followed by a 30-min global ischemia and 60-min reperfusion. Lactate, lactate dehydrogenase (LDH) and 2,5-dihydroxybenzoic acid (2,5-DHBA) concentrations in the effluent were measured during reperfusion. Three days' treatment with SMS (1.67 ml/kg per day) inhibited the rise in LVEDP and improved the post-ischemic LVDP and +/-dP/dt significantly better than in the untreated control hearts during reperfusion. SMS increased the coronary flow at baseline, and during reperfusion. Pretreatment with 5-hydroxydecanoic acid (5-HD), a mitochondrial KATP channel blocker, abolished the inhibition of the rise in LVEDP, the increase in coronary flow and the improvement in LVDP and +/-dP/dt induced by SMS. SMS significantly attenuated the concentrations of lactate, LDH and 2,5-DHBA during reperfusion, but the pretreatment with 5-HD restored them; 5-HD alone did not affect the concentrations. SMS improved the post-ischemic myocardial dysfunction through opening the mitochondrial KATP channels.


Asunto(s)
Adenosina Trifosfato/metabolismo , Cardiomiopatías/prevención & control , Cardiotónicos/uso terapéutico , Medicamentos Herbarios Chinos/uso terapéutico , Gentisatos , Mitocondrias Cardíacas/metabolismo , Isquemia Miocárdica/tratamiento farmacológico , Canales de Potasio/metabolismo , Animales , Combinación de Medicamentos , Hidroxibenzoatos/metabolismo , Técnicas In Vitro , L-Lactato Deshidrogenasa/metabolismo , Ácido Láctico/metabolismo , Masculino , Isquemia Miocárdica/fisiopatología , Miocardio/metabolismo , Canales de Potasio/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Recuperación de la Función , Función Ventricular Izquierda
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA